I believe Becker/Drapkin have holdings in more than one account. This may be a large, planned trade from one of their accounts to another.
Attracting the interest of a partner has more to do with the Tunisian political situation than the oil/gas market. The Western European market is a stone's throw from these fields. Who wants to explore/develop oil/gas with an interim North African government? PA Resources seems to be moving forward with development(installation of submersible pumps) and an exploration well project. Perhaps confidence in dealing with the state oil company has returned.
Over 400,000 traded yesterday, and the price doesn't move a penny. When will Becker decide to #$%$, and get off the pot? The pot of cash created from the sale of the business.
This question should be directed to Steven Becker. He's the one who orchestrated the fire sale of Strategic Diagnostics! Treasure chest of diminishing cash, and a whole lot of smoke.
Walkin' around Alberta, hawkin' vials of bull semen? Trinidad was the cowboy's last hurrah? North Africa, and hunt your own gusher, on a plot next to a major? Pluggin' a Nova Scotia gas find with hyberbole? Mamas, don't let your babies grow up to be Sonde investors!
Pile of cash and no revealed business plan. Open up a can of sardines, and it suddenly smells fishy! Sale of Life Science was approved by only 65% of the shares. Some endorsement of the Board's future intentions with Strategic Diversified Opportunities!
Guess what's coming to dinner? A genetically modified Steve Becker? Seriously, I don't understand. The thirteen million is for the entire antibody production business, not just the few GMO tests they have developed.
Does this accounting review imply that Steve and Fran can no longer be relied upon? With pockets stuffed with money, where are they taking this shell?
Sense of humor? Fran and Steve have left SDIX investors with little else. I wonder if the delay has to do with other offers, possibilities for Life Science. Whatever became of Padgett and NovusBio?
Let's see, they got 4.5 million for water test kits, 13.5 millions for food safety, and 16 million for antibodies. I suppose we remain in limbo until Becker decides what to do with the money!
If management were only more forthright with their plans, we wouldn't be so cynical of their intentions. Like Klaus, Fran slips out the backdoor without a peep.
Perhaps SDIX have patents or other intellectual properties that can generate royalties from Origene's future antibodies sales(Does this sale leave Novusbio and Karen Padgett out of the picture?). Becker and DiNuzzo have not been forthright with their investors, and all we can do is speculate about any future for SDIX.
for shareholders is a stock price of a dollar and a few pennies! Steven Becker, with the sale of antibodies production, what do you and DiNuzzo have up your riverboat gambling sleeves? What do you intend to do with the monies from the sales of test kits and life science? Like mushrooms, SDIX investors are being kept in the dark.
for basically what money they had in the rabbit/mice antibodies collection facilities. Their science, as a previous post pointed out, got squat! No wonder Klaus jumped ship in September. Was board member Steve Becker a facilitator in this transaction, covering his lost with a vested interest in Origene? Inquiring minds would like to know!